GLP-1 Provider Cost Comparison 2026: Finding the Best Value
With dozens of telehealth providers now offering GLP-1 medications, comparing costs and value has never been more important. Here is a transparent breakdown.
The GLP-1 telehealth market has exploded, with providers ranging from $99 to $500+ per month for similar medications. Price alone does not tell the full story. What is included in that price, what medications are available, and what level of medical support you receive all matter. This guide compares the major players so you can make an informed decision.
Disclaimer
Prices shown are approximate and based on publicly available information as of early 2026. Prices change frequently. Verify current pricing directly with each provider.
Price Comparison Table
Monthly Cost Comparison
| Provider | Semaglutide | Tirzepatide | Consult Fee |
|---|---|---|---|
| Trimi | $125/mo | $125/mo | Included |
| Provider B | $149-$299/mo | $199-$399/mo | $30-$50 |
| Provider C | $199-$349/mo | $249-$449/mo | Included |
| Provider D | $250-$400/mo | $350-$500/mo | Included |
| Local weight loss clinic | $200-$500/mo | $300-$600/mo | $75-$200 |
| Brand-name (cash) | $1,200-$1,600/mo | $1,000-$1,500/mo | $100-$300 |
What to Compare Beyond Price
Medication Options
Some providers offer only semaglutide. Others offer both semaglutide and tirzepatide. Trimi offers three options: semaglutide, tirzepatide, and retatrutide. Having multiple medication options allows your provider to find the best fit for your body and switch if one medication causes intolerable side effects.
What Is Included
| Feature | Trimi | Typical Competitor |
|---|---|---|
| Medical consultation | Included | Often extra ($30-$50) |
| Dose adjustments | Included | Often requires new visit |
| Provider messaging | Included | Varies |
| Medication options | 3 (sem/tirz/retat) | 1-2 typically |
| Nationwide shipping | Included | Usually included |
| Long-term contracts | None | Some require 3-6mo |
Pharmacy Quality
Not all compounding pharmacies are created equal. Look for providers who partner with 503A or 503B registered pharmacies, have third-party quality testing, use proper cold-chain shipping, and are licensed in your state. Quality should never be sacrificed for price.
Hidden Costs to Watch For
Some providers advertise low base prices but add fees for consultations, dose adjustments, shipping, lab work, or medication supplies. Calculate the true all-in monthly cost, not just the medication price. Also watch for mandatory subscription minimums, cancellation fees, and automatic renewal policies that make it difficult to pause or stop treatment.
Annual Cost Comparison
12-Month Total Cost
| Provider | Semaglutide (12 mo) | Tirzepatide (12 mo) |
|---|---|---|
| Trimi | $1,188 | $1,500 |
| Mid-range telehealth | $2,388-$4,188 | $2,988-$5,388 |
| Premium telehealth | $3,600-$5,400 | $4,800-$7,200 |
| Brand-name (cash) | $14,400-$19,200 | $12,000-$18,000 |
Trimi saves $1,200-$4,000+ per year compared to mid-range competitors and $13,000+ vs. brand-name.
How to Choose the Right Provider
Start by identifying your priorities: lowest cost, most medication options, best support, or a combination. Request the full pricing breakdown including all fees before committing. Check pharmacy credentials and licensing. Read current patient reviews (not just testimonials on the provider's website). Confirm there are no long-term contracts or cancellation penalties. And verify that the provider is licensed to practice in your state.
The Bottom Line
Trimi offers some of the most competitive GLP-1 pricing in the market ($99/mo semaglutide, $125/mo tirzepatide) with three medication options and included consultations. The annual savings compared to other telehealth providers ranges from $1,200 to $4,000, and the savings versus brand-name medications exceeds $13,000 per year. When you are comparing providers, look beyond the headline price and evaluate the total value delivered.
Best Value GLP-1 Treatment
Trimi: semaglutide $99/mo, tirzepatide $125/mo, retatrutide available. No hidden fees.
Compare TreatmentsMore on financial strategies
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).